The Wnt/β-catenin signalling pathway in Haematological Neoplasms
- PMID: 36224652
- PMCID: PMC9558365
- DOI: 10.1186/s40364-022-00418-9
The Wnt/β-catenin signalling pathway in Haematological Neoplasms
Abstract
Leukaemia and lymphoma are common malignancies. The Wnt pathway is a complex network of proteins regulating cell proliferation and differentiation, as well as cancer development, and is divided into the Wnt/β-catenin signalling pathway (the canonical Wnt signalling pathway) and the noncanonical Wnt signalling pathway. The Wnt/β-catenin signalling pathway is highly conserved evolutionarily, and activation or inhibition of either of the pathways may lead to cancer development and progression. The aim of this review is to analyse the mechanisms of action of related molecules in the Wnt/β-catenin pathway in haematologic malignancies and their feasibility as therapeutic targets.
Keywords: Haematologic neoplasms; Leukaemia; Lymphoma; Multiple myeloma; Wnt/β-catenin signalling pathway.
© 2022. The Author(s).
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Vleminckx K, Wong E, Guger K, Rubinfeld B, Polakis P, Gumbiner BM. Adenomatous polyposis coli tumor suppressor protein has signaling activity in Xenopus laevis embryos resulting in the induction of an ectopic dorsoanterior axis. J Cell Biol. 1997;136(2):411–20. doi: 10.1083/jcb.136.2.411. - DOI - PMC - PubMed
Publication types
Grants and funding
- No. 81372134/National Natural Science Foundation of China
- No. 81372134/National Natural Science Foundation of China
- No. 2021JJ30590/Natural Science Foundation of Hunan Province
- No. 2021JJ30590/Natural Science Foundation of Hunan Province
- 2014-405/Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study
LinkOut - more resources
Full Text Sources
